鳳祥股份(09977.HK):大股東附屬新鳳祥財務遭起訴
鳳祥股份(09977.HK)公布,控股股東鳳祥控股集團的附屬公司新鳳祥財務涉及逾期還款糾紛,被原告提出民事起訴,公司控股股東兼非執行董事劉學景亦被列為被告。
鳳祥股份表示,新鳳祥財務一直為集團提供存款、貸款融通(包括定期貸款及委託貸款)及票據融資服務,集團目前已經未能就日常經營而提取及動用存放的存款,新鳳祥財務亦於近日逾期向集團支付存款利息。截至11月17日,集團於新鳳祥財務的存款(包括相關應計利息)金額約8.155億元人民幣。
公司已經成立專責小組負責跟蹤新鳳祥財務的情況,管理層對有關情況也正考慮存款的其他保障措施,以維護集團及公司股東整體利益,現時亦正就最終債務處理方案的最差情況諮詢法律意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.